Early pathological changes in progressive multifocal leukoencephalopathy: a report of two asymptomatic cases

K E Aström1, G L Stoner

  • 1National Institutes of Health, Bethesda, MD 20892.

Acta Neuropathologica
|January 1, 1994
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) may start in astrocytes, which become reactive and spread JC virus (JCV) to oligodendrocytes. This study examines early PML lesions in non-AIDS cases.

Area of Science:

  • Neurovirology
  • Neuropathology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system (CNS) caused by JC virus (JCV).
  • The typical pathology involves JCV-infected oligodendrocytes leading to demyelination, primarily in non-AIDS patients.

Observation:

  • Serial sections of brain tissue from two asymptomatic, non-AIDS PML cases were analyzed using immunocytochemistry and myelin staining.
  • Early, small lesions and precursor lesions were identified in the gray and white matter.
  • Areas with enlarged, GFAP-positive astrocytes lacking viral antigen and myelin destruction were observed.

Findings:

  • JCV-infected oligodendrocytes were found in classical demyelinated lesions.
  • Enlarged astrocytes expressing GFAP, potentially as an early reactive change, were noted in proximity to infected oligodendrocytes.
  • Vacuolation, not previously associated with PML, was observed near lesions.

Implications:

  • The findings suggest PML may initiate in astrocytes, which become reactive and transmit JCV to oligodendrocytes.
  • This challenges the traditional view of PML solely as an oligodendrocyte disease.
  • Early detection of astroglial involvement could offer new diagnostic and therapeutic targets for PML.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...